Abbott Laboratories
-
{
- All
- News
- Videos
-
Government Caps Prices of 108 More Medicines; Drugmakers to Take Hit
- Thursday December 7, 2023
- Author: NDTV Profit Desk
The notice by the National Pharmaceutical Pricing Authority (NPPA), published on its website on Friday, coincides with moves by the health ministry to widen the list of essential medicines which will be subject to a price cap, people familiar with the matter told Reuters last month.
-
www.ndtvprofit.com
-
Prices of More Essential Drugs May be Capped: Report
- Thursday December 7, 2023
- Author: NDTV Profit Desk
The committee will consider adding more drugs to the National List of Essential Medicines (NLEM), all of which would then come under price controls, one of the people told Reuters.
-
www.ndtvprofit.com
-
Major Producer Finishes India Recall Of US Imported Baby Formula Products
- Friday May 20, 2022
- India News | Reuters
Abbott Laboratories' India unit has completed a recall of baby formula products that were manufactured at the company's troubled Michigan facility in the United States, a spokesperson for the company said on Friday.
-
www.ndtv.com
-
Biocon Says May Demerge Syngene in Long Run, Post IPO
- Thursday July 16, 2015
- Thomson Reuters
Syngene provides contract drug discovery, research and manufacturing services to 17 of the world's top 20 pharmaceutical companies, including Bristol Myers Squibb & Co and Abbott Laboratories Ltd. Its revenue rose 25 percent in the last three years.
-
www.ndtvprofit.com
-
Dow Surges 263 Points on Pharma Deals, China Stimulus Talk
- Tuesday March 31, 2015
- Thomson Reuters
Equity markets were also cheered by comments from People's Bank of China governor Zhou Xiaochuan that warned of disinflation and hinted at further monetary easing measures.
-
www.ndtvprofit.com
-
Piramal Plans $2 Billion Bet on Property Sector Revival
- Wednesday November 5, 2014
Piramal Enterprises Ltd plans to invest $2 billion (Rs 12,200 crore at 1 dollar = 61 rupees) in real estate projects over the next two years, betting that a revival in the economy under a new government will boost demand for property, its billionaire chief said.
-
www.ndtvprofit.com
-
Government Caps Prices of 108 More Medicines; Drugmakers to Take Hit
- Monday July 14, 2014
The notice by the National Pharmaceutical Pricing Authority (NPPA), published on its website on Friday, coincides with moves by the health ministry to widen the list of essential medicines which will be subject to a price cap, people familiar with the matter told Reuters last month.
-
www.ndtvprofit.com
-
Prices of More Essential Drugs May be Capped: Report
- Tuesday June 24, 2014
The committee will consider adding more drugs to the National List of Essential Medicines (NLEM), all of which would then come under price controls, one of the people told Reuters.
-
www.ndtvprofit.com
-
Big Pharma still betting on 'messed up' Indian drugs market
- Wednesday March 12, 2014
Global drug makers have had a nauseous time in India's $14-billion market. Prices have dropped and valuable patents have been overruled as the authorities strive to make medicines affordable for the 70 per cent of people living on less than $2 a day.
-
www.ndtvprofit.com
-
Big Pharma down, not out, after Novartis patent blow
- Wednesday April 3, 2013
Stung by a landmark patent defeat, Western drug-makers will be wary about launching new products in India, but they cannot afford to quit a country tipped to be the world's eighth largest market for medicines by 2016.
-
www.ndtvprofit.com
-
Abbott Labs agrees to pay $1.5 billion over Depakote
- Tuesday May 8, 2012
Depakote is an anti-seizure and mood-stabilizing drug prescribed for bipolar disorder. The company has pleaded guilty and agreed to pay $1.5 billion over allegations that it promoted the drug for uses that were not approved by the FDA.
-
www.ndtvprofit.com
-
Government Caps Prices of 108 More Medicines; Drugmakers to Take Hit
- Thursday December 7, 2023
- Author: NDTV Profit Desk
The notice by the National Pharmaceutical Pricing Authority (NPPA), published on its website on Friday, coincides with moves by the health ministry to widen the list of essential medicines which will be subject to a price cap, people familiar with the matter told Reuters last month.
-
www.ndtvprofit.com
-
Prices of More Essential Drugs May be Capped: Report
- Thursday December 7, 2023
- Author: NDTV Profit Desk
The committee will consider adding more drugs to the National List of Essential Medicines (NLEM), all of which would then come under price controls, one of the people told Reuters.
-
www.ndtvprofit.com
-
Major Producer Finishes India Recall Of US Imported Baby Formula Products
- Friday May 20, 2022
- India News | Reuters
Abbott Laboratories' India unit has completed a recall of baby formula products that were manufactured at the company's troubled Michigan facility in the United States, a spokesperson for the company said on Friday.
-
www.ndtv.com
-
Biocon Says May Demerge Syngene in Long Run, Post IPO
- Thursday July 16, 2015
- Thomson Reuters
Syngene provides contract drug discovery, research and manufacturing services to 17 of the world's top 20 pharmaceutical companies, including Bristol Myers Squibb & Co and Abbott Laboratories Ltd. Its revenue rose 25 percent in the last three years.
-
www.ndtvprofit.com
-
Dow Surges 263 Points on Pharma Deals, China Stimulus Talk
- Tuesday March 31, 2015
- Thomson Reuters
Equity markets were also cheered by comments from People's Bank of China governor Zhou Xiaochuan that warned of disinflation and hinted at further monetary easing measures.
-
www.ndtvprofit.com
-
Piramal Plans $2 Billion Bet on Property Sector Revival
- Wednesday November 5, 2014
Piramal Enterprises Ltd plans to invest $2 billion (Rs 12,200 crore at 1 dollar = 61 rupees) in real estate projects over the next two years, betting that a revival in the economy under a new government will boost demand for property, its billionaire chief said.
-
www.ndtvprofit.com
-
Government Caps Prices of 108 More Medicines; Drugmakers to Take Hit
- Monday July 14, 2014
The notice by the National Pharmaceutical Pricing Authority (NPPA), published on its website on Friday, coincides with moves by the health ministry to widen the list of essential medicines which will be subject to a price cap, people familiar with the matter told Reuters last month.
-
www.ndtvprofit.com
-
Prices of More Essential Drugs May be Capped: Report
- Tuesday June 24, 2014
The committee will consider adding more drugs to the National List of Essential Medicines (NLEM), all of which would then come under price controls, one of the people told Reuters.
-
www.ndtvprofit.com
-
Big Pharma still betting on 'messed up' Indian drugs market
- Wednesday March 12, 2014
Global drug makers have had a nauseous time in India's $14-billion market. Prices have dropped and valuable patents have been overruled as the authorities strive to make medicines affordable for the 70 per cent of people living on less than $2 a day.
-
www.ndtvprofit.com
-
Big Pharma down, not out, after Novartis patent blow
- Wednesday April 3, 2013
Stung by a landmark patent defeat, Western drug-makers will be wary about launching new products in India, but they cannot afford to quit a country tipped to be the world's eighth largest market for medicines by 2016.
-
www.ndtvprofit.com
-
Abbott Labs agrees to pay $1.5 billion over Depakote
- Tuesday May 8, 2012
Depakote is an anti-seizure and mood-stabilizing drug prescribed for bipolar disorder. The company has pleaded guilty and agreed to pay $1.5 billion over allegations that it promoted the drug for uses that were not approved by the FDA.
-
www.ndtvprofit.com